Table of Contents

2019-2024 Global Prostate Cancer Diagnostics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Diagnostics Consumption 2014-2024
2.1.2 Prostate Cancer Diagnostics Consumption CAGR by Region
2.2 Prostate Cancer Diagnostics Segment by Type
2.2.1 Tumor Biomarker Tests
2.2.2 Imaging
2.2.3 Biopsy
2.2.4 Other
2.3 Prostate Cancer Diagnostics Consumption by Type
2.3.1 Global Prostate Cancer Diagnostics Consumption Market Share by Type (2014-2019)
2.3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2014-2019)
2.3.3 Global Prostate Cancer Diagnostics Sale Price by Type (2014-2019)
2.4 Prostate Cancer Diagnostics Segment by Application
2.4.1 age < 55
2.4.2 age 55-75
2.4.3 age > 75
2.5 Prostate Cancer Diagnostics Consumption by Application
2.5.1 Global Prostate Cancer Diagnostics Consumption Market Share by Application (2014-2019)
2.5.2 Global Prostate Cancer Diagnostics Value and Market Share by Application (2014-2019)
2.5.3 Global Prostate Cancer Diagnostics Sale Price by Application (2014-2019)

3 Global Prostate Cancer Diagnostics by Players
3.1 Global Prostate Cancer Diagnostics Sales Market Share by Players
3.1.1 Global Prostate Cancer Diagnostics Sales by Players (2017-2019)
3.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Players (2017-2019)
3.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players
3.2.1 Global Prostate Cancer Diagnostics Revenue by Players (2017-2019)
3.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2017-2019)
3.3 Global Prostate Cancer Diagnostics Sale Price by Players
3.4 Global Prostate Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Prostate Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Prostate Cancer Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Prostate Cancer Diagnostics by Regions
4.1 Prostate Cancer Diagnostics by Regions
4.1.1 Global Prostate Cancer Diagnostics Consumption by Regions
4.1.2 Global Prostate Cancer Diagnostics Value by Regions
4.2 Americas Prostate Cancer Diagnostics Consumption Growth
4.3 APAC Prostate Cancer Diagnostics Consumption Growth
4.4 Europe Prostate Cancer Diagnostics Consumption Growth
4.5 Middle East & Africa Prostate Cancer Diagnostics Consumption Growth

5 Americas
5.1 Americas Prostate Cancer Diagnostics Consumption by Countries
5.1.1 Americas Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
5.1.2 Americas Prostate Cancer Diagnostics Value by Countries (2014-2019)
5.2 Americas Prostate Cancer Diagnostics Consumption by Type
5.3 Americas Prostate Cancer Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Prostate Cancer Diagnostics Consumption by Countries
6.1.1 APAC Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
6.1.2 APAC Prostate Cancer Diagnostics Value by Countries (2014-2019)
6.2 APAC Prostate Cancer Diagnostics Consumption by Type
6.3 APAC Prostate Cancer Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Prostate Cancer Diagnostics by Countries
7.1.1 Europe Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
7.1.2 Europe Prostate Cancer Diagnostics Value by Countries (2014-2019)
7.2 Europe Prostate Cancer Diagnostics Consumption by Type
7.3 Europe Prostate Cancer Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Diagnostics by Countries
8.1.1 Middle East & Africa Prostate Cancer Diagnostics Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Prostate Cancer Diagnostics Value by Countries (2014-2019)
8.2 Middle East & Africa Prostate Cancer Diagnostics Consumption by Type
8.3 Middle East & Africa Prostate Cancer Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Prostate Cancer Diagnostics Distributors
10.3 Prostate Cancer Diagnostics Customer

11 Global Prostate Cancer Diagnostics Market Forecast
11.1 Global Prostate Cancer Diagnostics Consumption Forecast (2019-2024)
11.2 Global Prostate Cancer Diagnostics Forecast by Regions
11.2.1 Global Prostate Cancer Diagnostics Forecast by Regions (2019-2024)
11.2.2 Global Prostate Cancer Diagnostics Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Prostate Cancer Diagnostics Forecast by Type
11.8 Global Prostate Cancer Diagnostics Forecast by Application

12 Key Players Analysis
12.1 Genomic Health
12.1.1 Company Details
12.1.2 Prostate Cancer Diagnostics Product Offered
12.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Genomic Health News
12.2 Abbott
12.2.1 Company Details
12.2.2 Prostate Cancer Diagnostics Product Offered
12.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Abbott News
12.3 OPKO
12.3.1 Company Details
12.3.2 Prostate Cancer Diagnostics Product Offered
12.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 OPKO News
12.4 Siemens Healthcare
12.4.1 Company Details
12.4.2 Prostate Cancer Diagnostics Product Offered
12.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Siemens Healthcare News
12.5 DiaSorin
12.5.1 Company Details
12.5.2 Prostate Cancer Diagnostics Product Offered
12.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 DiaSorin News
12.6 BioMeriux
12.6.1 Company Details
12.6.2 Prostate Cancer Diagnostics Product Offered
12.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 BioMeriux News
12.7 Roche
12.7.1 Company Details
12.7.2 Prostate Cancer Diagnostics Product Offered
12.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Roche News
12.8 MDx Health
12.8.1 Company Details
12.8.2 Prostate Cancer Diagnostics Product Offered
12.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 MDx Health News
12.9 Beckman Coulter
12.9.1 Company Details
12.9.2 Prostate Cancer Diagnostics Product Offered
12.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Beckman Coulter News
12.10 Myriad Genetics
12.10.1 Company Details
12.10.2 Prostate Cancer Diagnostics Product Offered
12.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Myriad Genetics News
12.11 Ambry Genetics

13 Research Findings and Conclusion